ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,445Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 1206

$959K Total Retail Price of All Prescriptions

Rank: 8 out of 1206

650 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 650 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

12% of this provider’s 650 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 13,198 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 700 596 1 2
SIMVASTATIN 632 514 2 1
OMEPRAZOLE 602 460 3 3
HYDROCODONE-ACETAMINOPHEN 560 411 S3 4 7
FUROSEMIDE 510 419 5 5
LISINOPRIL 363 276 6 4
POTASSIUM CHLORIDE 354 272 7 12
AMLODIPINE BESYLATE 314 252 8 6
WARFARIN SODIUM 286 249 9 8
METFORMIN HCL 279 190 10 10
PRAVASTATIN SODIUM 278 240 11 21
METOPROLOL TARTRATE 254 178 12 9
ATORVASTATIN CALCIUM 234 200 13 13
ATENOLOL 234 200 13 14
TRAZODONE HCL 226 158 15 37
METOPROLOL SUCCINATE 219 197 16 15
FLUTICASONE PROPIONATE 215 154 17 42
HYDROCHLOROTHIAZIDE 210 172 18 11
NAMENDA 202 185 19 36
CITALOPRAM HBR 200 177 20 16
BISOPROLOL-HYDROCHLOROTHIAZIDE 190 131 21 108
DONEPEZIL HCL 187 171 22 29
TRAMADOL HCL 180 147 23 17
ESCITALOPRAM OXALATE 174 124 24 86
GABAPENTIN 172 86 25 18
ALENDRONATE SODIUM 146 135 26 19
LANTUS 141 123 27 38
BENAZEPRIL HCL 139 111 28 39
RISPERIDONE 137 120 29 74
MELOXICAM 128 67 30 35
RANITIDINE HCL 127 96 31 23
ZOLPIDEM TARTRATE 124 111 32 25
FENTANYL 121 104 S2 33 51
LOSARTAN POTASSIUM 114 96 34 20
TAMSULOSIN HCL 112 101 35 26
FENOFIBRATE 107 52 36 56
POLYETHYLENE GLYCOL 3350 106 83 37 31
PROPRANOLOL HCL 104 60 38 92
ENALAPRIL MALEATE 103 82 39 45
GLIMEPIRIDE 102 79 40 34
MIRTAZAPINE 99 94 41 50
DIGOXIN 98 62 42 43
GLYBURIDE 96 87 R 43 69
NOVOLOG 95 81 44 100
AZITHROMYCIN 94 65 45 46
ALLOPURINOL 94 72 45 24
LEVOFLOXACIN 92 76 47 78
VESICARE 86 58 48 148
PROAIR HFA 86 37 48 49
BACLOFEN 84 18 50 137
PEN NEEDLE 84 74 50 121
SERTRALINE HCL 83 72 52 22
CRESTOR 82 65 53 30
PLAVIX 81 61 54 72
NEXIUM 81 40 54 47
QUETIAPINE FUMARATE 80 50 56 79
SULFAMETHOXAZOLE-TRIMETHOPRIM 72 56 57 82
LANTUS SOLOSTAR 71 62 58 85
BENZTROPINE MESYLATE 67 52 R 59 180
DIOVAN 66 47 60 57
ADVAIR DISKUS 66 51 60 55
CYMBALTA 66 51 60 63
PAROXETINE HCL 66 55 60 53
CEFTRIAXONE 65 58 64 277
NABUMETONE 64 42 65 91
LEVETIRACETAM 63 30 66 135
DIVALPROEX SODIUM 60 39 67 153
METRONIDAZOLE 59 53 68 315
CLOPIDOGREL 57 56 69 48
LISINOPRIL-HYDROCHLOROTHIAZIDE 56 45 70 27
TERAZOSIN HCL 56 56 70 81
FAMOTIDINE 55 47 72 65
PRAMIPEXOLE DIHYDROCHLORIDE 55 40 72 142
ISOSORBIDE MONONITRATE ER 54 46 74 40
EVISTA 54 54 74 129
SPIRIVA 52 28 76 66
METHYLPREDNISOLONE 52 31 76 197
SPIRONOLACTONE 52 36 76 41
NYSTATIN 52 31 76 166
NYSTATIN-TRIAMCINOLONE 51 32 80 208
ROPINIROLE HCL 50 48 81 77
PREMARIN 50 41 R 81 147
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.